How to use the speech recognition tool?
NCT04285398
PHENOROD2
Prospective Natural History Study of Retinitis Pigmentosa (PHENOROD2)
Type: Observational
Status of the trial: Active, Recruiting
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2020-02-01
- Closing Date: 2020-03-01
Criteria
Inclusion: RP with mutations affecting the RHO, PDE6A and PDE6B genes Visual acuity ≥ 20/200 for at least one eye Binocular Visual field diameter ≥ 5° as measured on the Goldmann III-4e isopter
Exclusion: Patients with any other gene mutation known to be involved in RP Patients with other ocular disorder likely to impact the visual function Pregnant or breastfeeding women
Children: No
Adults: Yes
Funder Type: private
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)